Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma

Objective To analyze the safety and efficacy of pemetrexed-based chemotherapy on patients with mid-elderly non-Hodgkin's lymphoma. Methods We retrospectively reviewed the clinical data of patients with non-Hodgkin's lymphoma treated with pemetrexed-based chemotherapy regimen from November...

Full description

Bibliographic Details
Main Authors: WEN Tingyu, GUI Lin, JIN Jun, ZHANG Wei, WANG Ting, SHI Yuankai, LIU Peng
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2020-02-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.1003.htm
_version_ 1828388705873690624
author WEN Tingyu
GUI Lin
JIN Jun
ZHANG Wei
WANG Ting
SHI Yuankai
LIU Peng
author_facet WEN Tingyu
GUI Lin
JIN Jun
ZHANG Wei
WANG Ting
SHI Yuankai
LIU Peng
author_sort WEN Tingyu
collection DOAJ
description Objective To analyze the safety and efficacy of pemetrexed-based chemotherapy on patients with mid-elderly non-Hodgkin's lymphoma. Methods We retrospectively reviewed the clinical data of patients with non-Hodgkin's lymphoma treated with pemetrexed-based chemotherapy regimen from November 2016 to October 2018 in the Cancer Hospital of Chinese Academy of Medical Sciences, and systematically reviewed the relevant literatures. Results We enrolled 10 patients with non-Hodgkin's lymphoma treated with pemetrexed-based chemotherapy: 7 cases of diffuse large B-cell lymphoma, 2 cases of angioimmunoblastic T cell lymphoma and one case of extranodal NK/T cell lymphoma. After tumor recurrence or progression, these patients were treated with pemetrexed-based chemotherapy. Four cases of diffuse large B-cell lymphoma reached partial remission and three cases progressed. The main adverse events were low grade myelosuppression and gastrointestinal reactions. Conclusion Pemetrexed-based chemotherapy regimen may have certain effectiveness and safety on the patients with diffuse large B-cell lymphoma, especially primary central nervous system lymphoma.
first_indexed 2024-12-10T06:17:22Z
format Article
id doaj.art-baf4b651f4a84cb8a34e26854fa9e272
institution Directory Open Access Journal
issn 1000-8578
1000-8578
language zho
last_indexed 2024-12-10T06:17:22Z
publishDate 2020-02-01
publisher Magazine House of Cancer Research on Prevention and Treatment
record_format Article
series Zhongliu Fangzhi Yanjiu
spelling doaj.art-baf4b651f4a84cb8a34e26854fa9e2722022-12-22T01:59:25ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85781000-85782020-02-0147211912310.3971/j.issn.1000-8578.2020.19.10038578.2020.19.1003Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's LymphomaWEN Tingyu0GUI Lin1JIN Jun2ZHANG Wei3WANG Ting4SHI Yuankai5LIU Peng6Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, ChinaDepartment of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, ChinaDepartment of Internal Medicine, Sanhuan Cancer Hospital, Beijing 100021, ChinaDepartment of Internal Medicine, Sanhuan Cancer Hospital, Beijing 100021, ChinaDepartment of Internal Medicine, Sanhuan Cancer Hospital, Beijing 100021, ChinaDepartment of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, ChinaDepartment of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, ChinaObjective To analyze the safety and efficacy of pemetrexed-based chemotherapy on patients with mid-elderly non-Hodgkin's lymphoma. Methods We retrospectively reviewed the clinical data of patients with non-Hodgkin's lymphoma treated with pemetrexed-based chemotherapy regimen from November 2016 to October 2018 in the Cancer Hospital of Chinese Academy of Medical Sciences, and systematically reviewed the relevant literatures. Results We enrolled 10 patients with non-Hodgkin's lymphoma treated with pemetrexed-based chemotherapy: 7 cases of diffuse large B-cell lymphoma, 2 cases of angioimmunoblastic T cell lymphoma and one case of extranodal NK/T cell lymphoma. After tumor recurrence or progression, these patients were treated with pemetrexed-based chemotherapy. Four cases of diffuse large B-cell lymphoma reached partial remission and three cases progressed. The main adverse events were low grade myelosuppression and gastrointestinal reactions. Conclusion Pemetrexed-based chemotherapy regimen may have certain effectiveness and safety on the patients with diffuse large B-cell lymphoma, especially primary central nervous system lymphoma.http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.1003.htmnon-hodgkin's lymphomadiffuse large b-cell lymphomapemetrexedchemotherapy
spellingShingle WEN Tingyu
GUI Lin
JIN Jun
ZHANG Wei
WANG Ting
SHI Yuankai
LIU Peng
Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma
Zhongliu Fangzhi Yanjiu
non-hodgkin's lymphoma
diffuse large b-cell lymphoma
pemetrexed
chemotherapy
title Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma
title_full Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma
title_fullStr Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma
title_full_unstemmed Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma
title_short Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma
title_sort retrospective analysis of pemetrexed based chemotherapy regimens on mid elderly non hodgkin s lymphoma
topic non-hodgkin's lymphoma
diffuse large b-cell lymphoma
pemetrexed
chemotherapy
url http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.1003.htm
work_keys_str_mv AT wentingyu retrospectiveanalysisofpemetrexedbasedchemotherapyregimensonmidelderlynonhodgkinslymphoma
AT guilin retrospectiveanalysisofpemetrexedbasedchemotherapyregimensonmidelderlynonhodgkinslymphoma
AT jinjun retrospectiveanalysisofpemetrexedbasedchemotherapyregimensonmidelderlynonhodgkinslymphoma
AT zhangwei retrospectiveanalysisofpemetrexedbasedchemotherapyregimensonmidelderlynonhodgkinslymphoma
AT wangting retrospectiveanalysisofpemetrexedbasedchemotherapyregimensonmidelderlynonhodgkinslymphoma
AT shiyuankai retrospectiveanalysisofpemetrexedbasedchemotherapyregimensonmidelderlynonhodgkinslymphoma
AT liupeng retrospectiveanalysisofpemetrexedbasedchemotherapyregimensonmidelderlynonhodgkinslymphoma